TVTX
Travere Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.93B
P/E Ratio
—
EPS
$-0.57
Beta
0.87
52W High
$42.13
52W Low
$13.14
50-Day MA
$29.30
200-Day MA
$26.68
Dividend Yield
—
Profit Margin
-5.21%
Forward P/E
46.51
PEG Ratio
—
About Travere Therapeutics Inc
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development and commercialization of therapies for the treatment of rare diseases. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $490.73M |
| Gross Profit (TTM) | $274.38M |
| EBITDA | $-2.08M |
| Operating Margin | -25.00% |
| Return on Equity | -57.80% |
| Return on Assets | -6.55% |
| Revenue/Share (TTM) | $5.50 |
| Book Value | $1.26 |
| Price-to-Book | 24.45 |
| Price-to-Sales (TTM) | 5.95 |
| EV/Revenue | 5.73 |
| EV/EBITDA | 126.64 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 73.40% |
| Shares Outstanding | $92.37M |
| Float | $91.22M |
| % Insiders | 0.69% |
| % Institutions | 115.81% |
Historical Volatility
HV 10-Day
53.55%
HV 20-Day
50.08%
HV 30-Day
50.33%
HV 60-Day
61.33%
HV Rank
26.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($42.50 target)
1
Strong Buy12
Buy2
HoldData last updated: 4/9/2026